Translating Genomic Discoveries into Therapies with Triparna Sen – GRACE
GRACE shared a post on X:
“Dr. Triparna Sen is an Associate Professor of Oncological Sciences and Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. Her groundbreaking research focuses on the biology of lung cancer initiation, progression, and drug resistance, uncovering therapeutic vulnerabilities to advance treatment outcomes.
Dr. Sen has made transformative contributions to understanding molecular subsets of lung cancer, particularly small cell lung cancer (SCLC).
To learn more about Dr. Triparna Sen click here.
To register for the event click here.”
H. Jack West, Vice President of Clinical Development at Summit Therapeutics, shared this post, adding:
“One of the most brilliant and dedicated clinical researchers on small cell lung cancer anywhere, along with Misty Dawn Shields. Doing amazing work!! So grateful they both share their expertise with patients and caregivers in GRACE programs.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023